Vanda secures FDA approval for Fanapt to treat bipolar I, 15 years after schizophrenia nod
Fierce Pharma
APRIL 3, 2024
Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychotic drug. The FDA has signed off on Fanapt tablets to treat adults with manic or mixed episodes associated with bipolar I disorder.
255 
Let's personalize your content